Evolving Treatment Modalities for Management of Patients Suffering From Disc Displacement With Reduction
NCT ID: NCT05194488
Last Updated: 2023-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2022-01-10
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low level laser therapy
Low level laser therapy
Patients will receive low-level laser therapy on the temporomandibular joint disc
Botulinum toxin type A
Botulinum toxin type A
Patients will receive Botulinum toxin type A injection into the lateral pterygoid muscle under Electromyography (EMG) guidance.
Anterior repositioning appliance
Anterior repositioning appliance
Patients will receive hard maxillary anterior repositioning appliance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low level laser therapy
Patients will receive low-level laser therapy on the temporomandibular joint disc
Botulinum toxin type A
Patients will receive Botulinum toxin type A injection into the lateral pterygoid muscle under Electromyography (EMG) guidance.
Anterior repositioning appliance
Patients will receive hard maxillary anterior repositioning appliance.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with anterior disc displacement as detected by MRI.
* Presence of full or nearly full complement of natural teeth.
Exclusion Criteria
* Patients who have anterior disc dislocation without reduction.
* Previous history of TMD treatment.
* History of recent trauma.
* The presence of systemic diseases (i.e. rheumatoid arthritis, osteoarthritis).
* Inability or unwillingness to undergo magnetic resonance imaging (MRI) such as implanted electronic devices.
* Pregnant and lactating females.
* Patients with known allergy to botulinum toxin type A.
* Patients suffering from neurological disorders.
20 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nourhan M.Aly
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nourhan M.Aly
Assistant Lecturer of Dental Public Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariam M Bahgat, M.Sc
Role: PRINCIPAL_INVESTIGATOR
Faculty of Dentistry, Alexandria University, Egypt
Nermeen A Rady, PhD
Role: STUDY_DIRECTOR
Faculty of Dentistry, Alexandria University, Egypt
Ahmed M Abdelhamid, PhD
Role: STUDY_CHAIR
Faculty of Dentistry, Alexandria University, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry, Alexandria University
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rady NA, Bahgat MM, Abdel-Hamid AM. Promising minimally invasive treatment modalities for symptomatic temporomandibular joint disc displacement with reduction: a randomized controlled clinical trial. BMC Oral Health. 2022 Dec 1;22(1):547. doi: 10.1186/s12903-022-02579-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB 00010556
Identifier Type: -
Identifier Source: org_study_id